Paper57791
The effect of bleomycin and pentamycin in combination on the survival of EMT6 mouse tumour cells in vitro and in vivo.
Twentyman PR. Br J Cancer, 1976. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. The effect of bleomycin and pentamycin in combination on the survival of EMT6 mouse tumour cells in vitro and in vivo. Papers, record 57791. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/57791
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effect of bleomycin and pentamycin in combination on the survival of EMT6 mouse tumour cells in vitro and in vivo.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifungal Agents | Major topic |
| Bleomycin | Major topic |
| Cell Survival | Major topic |
| Animals | |
| Cell Line | |
| Cell Membrane | |
| Dose-Response Relationship, Drug | |
| Drug Synergism | |
| In Vitro Techniques | |
| Macrolides | |
| Mice | |
| Neoplasms, Experimental | |
| Polyenes | |
| Time Factors |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4138662 | Radioautographic studies on the intracellular distribution of bleomycin-14C in mouse tumor cells. | Cancer Res | 1974 | https://conductscience.org/library/papers/4138662 | PubMed |
| 2 | 4138969 | Potentiation of bleomycin by an antifungal polyene, pentamycin, in transformed animal cells. | Cancer Res | 1974 | https://conductscience.org/library/papers/4138969 | PubMed |
| 3 | 4143273 | The sensitivity to bleomycin of a solid mouse tumour at different stages of growth. | Br J Cancer | 1974 | https://conductscience.org/library/papers/4143273 | PubMed |
| 4 | 4823906 | Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia. | Cancer Res | 1974 | https://conductscience.org/library/papers/4823906 | PubMed |
| 5 | 4121070 | Effect of bleomycin on mammalian cell survival. | J Natl Cancer Inst | 1972 | https://conductscience.org/library/papers/4121070 | PubMed |
| 6 | 4133497 | Potentiation of 5-fluorouracil, chromomycin A3, and bleomycin by amphotericin B or polymyxin B in transformed fibroblastic cells. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4133497 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/57791
GET https://conductscience.org/api/papers/v1/57791/authors